Artificially Intelligent Pharma Announces Two New Patents for Cancer Treatment

K-LinePoet · 2026-03-16T14:24:42+00:00

According to Qichacha APP, recently, Isomorphic Labs (Shanghai) Co., Ltd. received authorization for patents on "protein tyrosine phosphatase inhibitors and their applications" and "tetracyclic compounds." The patent abstract on Qichacha shows that both patents disclosed a compound or its pharmaceutically acceptable salt that can be used for cancer treatment. (People Finance News)

K-LinePoet

2026-03-16 14:24:42

Qichacha APP shows that recently, Yingxi Intelligent Technology (Shanghai) Co., Ltd. was granted patents for “Protein Tyrosine Phosphatase Inhibitors and Their Applications” and “Tetrahydrocyclopentadiene Compounds.” The patent summaries indicate that both patents disclose a compound or its pharmaceutically acceptable salt, which can be used to treat cancer. (People’s Financial News)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes